Do you want to read an article? Please log in or register.
Stratified analysis of carotid plaque and intima-media thickness as stroke predictors in type 2 diabetes
Thrombosis and Stroke
Related content
Heart, Artery and Coronary Diseases
Lipidomic analysis reveals metabolism alteration associated with subclinical carotid atherosclerosis in type 2 diabetes
Cardiovasc Diabetol
Barranco-Altirriba M, Rossell J, Alonso N, Weber RJM, Ortega E, Lloyd GR, Hernandez M, Yanes O, Capellades J, Winder C, Junza A, Falguera M, Franch-Nadal J, Dunn WB, Perera-Lluna A, Castelblanco E, Mauricio D
doi: 10.1186/s12933-025-02701-z
COMMENTED
Cardiovascular Risk and Diseases
Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Patsoukaki V, Lind L, Lampa E, Radhi S, Eeg-Olofsson K, Eliasson B, Eriksson JW
doi: 10.1016/S2213-8587(25)00165-2
Further Publications
Unsupervised Learning Analysis of Triglycerides, Inflammation, Cholesterol, and the Risks of Incident Cardiovascular Disease and Type 2 Diabetes in the Women's Health Study
J Am Heart Assoc
Duran EK, Cook NR, Aday AW, Buring JE, Ridker PM, Pradhan AD
doi: 10.1161/JAHA.123.039381
Heart Failure
Mortality risk following ischaemic and non-ischaemic heart failure in people with type 2 diabetes: Observational study in England, 2000-2021
Diabetes Obes Metab
Panchal K, Lawson CA, Shabnam S, Khunti K, Zaccardi F
doi: 10.1111/dom.16413
Cardiovascular Risk and Diseases
Low serum 1,5-anhydroglucitol is associated with increased risk of all-cause and cardiovascular mortality in type 2 diabetes: A real-world cohort study
Diabetes Obes Metab
Ni J, Chen L, Su H, Cai J, Wang C, Lu W, Wang Y, Lu J, Xia T, Zhou J
doi: 10.1111/dom.70214
COMMENTED
Cardiovascular Risk and Diseases
Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
N Engl J Med
McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JFE, Emerson SS, Poulter NR, Engelmann MDM, Ripa MS, Hovingh GK, Brown-Frandsen K, Bain SC, Cavender MA, Gislum M, David JP, Buse JB, SOUL Study Group
doi: 10.1056/NEJMoa2501006
COMMENTED
Cardiovascular Risk and Diseases
Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Lancet Diabetes Endocrinol
Hauge JW, Borgeraas H, Birkeland KI, Johnson LK, Hertel JK, Hagen M, Gulseth HL, Lindberg M, Lorentzen J, Seip B, Kolotkin RL, Svanevik M, Valderhaug TG, Sandbu R, Hjelmesæth J, Hofsø D
doi: 10.1016/S2213-8587(24)00396-6
Heart, Artery and Coronary Diseases
Risk of coronary artery disease in intermediate hyperglycemia and type 2 diabetes defined by 1-hour post-load glucose levels according to the new IDF criteria
Diabetes Res Clin Pract
Vanessa Fiorentino T, Maria Assunta Cefalo C, Rubino M, Riccio A, Succurro E, Cassano V, Chiara Mannino G, Perticone M, Sciacqua A, Andreozzi F, Sesti G
doi: 10.1016/j.diabres.2026.113100
Cardiovascular Risk and Diseases
Comparison of Semaglutide or Dulaglutide Versus Empagliflozin for Risk for Death and Cardiovascular Outcomes Among Patients With Type 2 Diabetes : Two Target Trial Emulation Studies
Ann Intern Med
Saeed A, Mulukutla SR, Thoma F, Lemon L, Koczo A, Reis S, Marroquin O, Kip K
doi: 10.7326/ANNALS-24-00775